Press Releases
FORT LAUDERDALE, Fla., July 29, 2019 /PRNewswire/ -- The U.S. is currently in the midst of a concussion epidemic with 5 million cases diagnosed annually. Despite what you might think, it's not just football players who are sustaining these potentially life-changing brain injuries, it is ordinary adults and children.The good news is that there are effec
Read more...NEW YORK, July 29, 2019 /PRNewswire/ -- Renalytix AI plc (LON: RENX), a developer of artificial intelligence-enabled diagnostics for kidney disease, announces the expansion of its leadership team
Read more...TORONTO, July 29, 2019 /PRNewswire/ -- Grandmaster Stanley Ngui is excited to announce two upcoming events, where he will be discussing his innovative new pain management technique, the NGUI-MATRIX, as well as natural medicine and its applications. Grandmaster Stanley Ngui is excited to announce that he
Read more...WOOD DALE, Ill., July 29, 2019 /PRNewswire/ -- The Radcliff (www.TheRadcliff.com) breaks from industry norms again, announcing today a new pricing structure that disrupts and elevates
Read more...29 July 2019
DENVER, July 29, 2019 /PRNewswire/ -- Following the decriminalization of psilocybin-containing "magic" mushrooms by Denver voters, Sträva has begun exploring the benefits and risks of combining micro-doses of psilocybin with their specialty coffee and tea products. Sträva CEO, Andrew Aamot, sh
Read more...VANCOUVER, July 29, 2019 /PRNewswire/ - CRH Medical Corporation (TSX: CRH) (NYSE MKT: CRHM) (the "Company"), plans to release its results for the quarter ended June 30, 2019 on Wednesday, July 31, 2019 after market close.The Company's executive management will discuss the results during a conf
Read more...BALTIMORE, July 29, 2019 /PRNewswire/ -- Medifast, (NYSE: MED), a leading manufacturer and distributor of clinically proven programs and healthy living products, today announced record-
Read more...HENDERSON, Nevada, July 29, 2019 /PRNewswire/ -- Leading Edge Pharms, Inc. (Leading Edge), a biotechnology company developing novel cannabinoid therapies and innovative delivery systems, announced today that former professional basketball player and
Read more...TEL AVIV, Israel, July 29, 2019 /PRNewswire/ -- Galmed Pharmaceuticals Ltd. (Nasdaq: GLMD) ("Galmed" or the "Company"), a clinical-stage biopharmaceutical company focused on the development of the liver targeted SCD1 modulator, Aramchol, an oral therapy for the treatment of nonalcoholic steatohepatitis (NASH) and fibrosis, announced today that it will host a confere
Read more...